Log In
Print
BCIQ
Print
Print this Print this
 

RDX002

  Manage Alerts
Collapse Summary General Information
Company Ardelyx Inc.
DescriptionNon-absorbed NaP2b phosphate transport inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Renal (unspecified)
Indication DetailsTreat chronic kidney disease (CKD)
Regulatory Designation

Partner

Sanofi


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today